Drugs / Cord Blood Graft
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05884333 | May 2023 → May 2028 expected | acute lymphoblastic leukemia, acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndrome | Memorial Sloan Kettering Cancer Center | Recruiting | No outcome recorded |
| Phase 2 | NCT04644016 | Nov 2020 → Dec 2026 expected | acute myeloid leukemia, bone marrow failure syndrome, hemophagocytic syndrome, inborn errors of metabolism +3 | Memorial Sloan Kettering Cancer Center | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cord blood graft | “Cord blood graft” NCT05884333 ↗ |